IBDEI0FN ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7194,2)
 ;;=^336536
 ;;^UTILITY(U,$J,358.3,7195,0)
 ;;=780.57^^31^434^1
 ;;^UTILITY(U,$J,358.3,7195,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7195,1,4,0)
 ;;=4^780.57
 ;;^UTILITY(U,$J,358.3,7195,1,5,0)
 ;;=5^Sleep Apnea NOS
 ;;^UTILITY(U,$J,358.3,7195,2)
 ;;=^332928
 ;;^UTILITY(U,$J,358.3,7196,0)
 ;;=780.50^^31^434^2
 ;;^UTILITY(U,$J,358.3,7196,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7196,1,4,0)
 ;;=4^780.50
 ;;^UTILITY(U,$J,358.3,7196,1,5,0)
 ;;=5^Sleep Disturbance NOS
 ;;^UTILITY(U,$J,358.3,7196,2)
 ;;=^111287
 ;;^UTILITY(U,$J,358.3,7197,0)
 ;;=V12.51^^31^435^2
 ;;^UTILITY(U,$J,358.3,7197,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7197,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,7197,1,5,0)
 ;;=5^HX Ven Thrombosis/Embolism
 ;;^UTILITY(U,$J,358.3,7197,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,7198,0)
 ;;=453.40^^31^435^1
 ;;^UTILITY(U,$J,358.3,7198,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7198,1,4,0)
 ;;=4^453.40
 ;;^UTILITY(U,$J,358.3,7198,1,5,0)
 ;;=5^Deep Venous Thrombosis
 ;;^UTILITY(U,$J,358.3,7198,2)
 ;;=^338554
 ;;^UTILITY(U,$J,358.3,7199,0)
 ;;=212.3^^31^436^2
 ;;^UTILITY(U,$J,358.3,7199,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7199,1,4,0)
 ;;=4^212.3
 ;;^UTILITY(U,$J,358.3,7199,1,5,0)
 ;;=5^Benign Tumor Lung/Bronch
 ;;^UTILITY(U,$J,358.3,7199,2)
 ;;=^267600
 ;;^UTILITY(U,$J,358.3,7200,0)
 ;;=162.9^^31^436^3
 ;;^UTILITY(U,$J,358.3,7200,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7200,1,4,0)
 ;;=4^162.9
 ;;^UTILITY(U,$J,358.3,7200,1,5,0)
 ;;=5^Carcinoma Lung Unspec Site
 ;;^UTILITY(U,$J,358.3,7200,2)
 ;;=^73521
 ;;^UTILITY(U,$J,358.3,7201,0)
 ;;=786.6^^31^436^4
 ;;^UTILITY(U,$J,358.3,7201,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7201,1,4,0)
 ;;=4^786.6
 ;;^UTILITY(U,$J,358.3,7201,1,5,0)
 ;;=5^Lung Mass
 ;;^UTILITY(U,$J,358.3,7201,2)
 ;;=^273380
 ;;^UTILITY(U,$J,358.3,7202,0)
 ;;=162.9^^31^436^5
 ;;^UTILITY(U,$J,358.3,7202,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7202,1,4,0)
 ;;=4^162.9
 ;;^UTILITY(U,$J,358.3,7202,1,5,0)
 ;;=5^Mesothelioma,Lung
 ;;^UTILITY(U,$J,358.3,7202,2)
 ;;=^73521
 ;;^UTILITY(U,$J,358.3,7203,0)
 ;;=197.0^^31^436^6
 ;;^UTILITY(U,$J,358.3,7203,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7203,1,4,0)
 ;;=4^197.0
 ;;^UTILITY(U,$J,358.3,7203,1,5,0)
 ;;=5^Metastatic Neo Lung
 ;;^UTILITY(U,$J,358.3,7203,2)
 ;;=^267322
 ;;^UTILITY(U,$J,358.3,7204,0)
 ;;=518.89^^31^436^7
 ;;^UTILITY(U,$J,358.3,7204,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7204,1,4,0)
 ;;=4^518.89
 ;;^UTILITY(U,$J,358.3,7204,1,5,0)
 ;;=5^Pulmonary Nodule
 ;;^UTILITY(U,$J,358.3,7204,2)
 ;;=^87486
 ;;^UTILITY(U,$J,358.3,7205,0)
 ;;=789.30^^31^436^1
 ;;^UTILITY(U,$J,358.3,7205,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7205,1,4,0)
 ;;=4^789.30
 ;;^UTILITY(U,$J,358.3,7205,1,5,0)
 ;;=5^Abdominal Mass
 ;;^UTILITY(U,$J,358.3,7205,2)
 ;;=^917
 ;;^UTILITY(U,$J,358.3,7206,0)
 ;;=441.4^^31^437^1
 ;;^UTILITY(U,$J,358.3,7206,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7206,1,4,0)
 ;;=4^441.4
 ;;^UTILITY(U,$J,358.3,7206,1,5,0)
 ;;=5^Abdom Aortic Aneurysm
 ;;^UTILITY(U,$J,358.3,7206,2)
 ;;=^269769
 ;;^UTILITY(U,$J,358.3,7207,0)
 ;;=453.40^^31^437^2
 ;;^UTILITY(U,$J,358.3,7207,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7207,1,4,0)
 ;;=4^453.40
 ;;^UTILITY(U,$J,358.3,7207,1,5,0)
 ;;=5^Deep Venous Thrombosis
 ;;^UTILITY(U,$J,358.3,7207,2)
 ;;=^338554
 ;;^UTILITY(U,$J,358.3,7208,0)
 ;;=443.9^^31^437^3
 ;;^UTILITY(U,$J,358.3,7208,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7208,1,4,0)
 ;;=4^443.9
 ;;^UTILITY(U,$J,358.3,7208,1,5,0)
 ;;=5^Peripheral Vascular Disease
 ;;^UTILITY(U,$J,358.3,7208,2)
 ;;=^184182
 ;;
 ;;$END ROU IBDEI0FN
